are they discontinuing tirzepatide being discontinued FDA has announced that the shortage of #tirzepatide, the ingredient in Lilly's Mounjaro and Zepbound, has been resolved. Compounding #pharmacies required to cease Tirzepatide Mechanism of Weight Loss

In a statement released March 10, Novo Nordisk said it initially received inspectional observations from the FDA in February 2025, and that it has been working diligently to address those observations ever since. In the statement on Tuesday, the drugmaker acknowledged it received the warning letter and that it welcomes further dialogue with the US FDA. The company said it is working diligently to address the concerns of the FDA

"A lot of us need to be better at that, 'cause we'reI'ma go, go, go, go," Kelly said

Because the injection bypasses the digestive system, nutrients are rapidly absorbed into the bloodstream

Review the Canada page Check the listed offer, read the product information, and review available COAs before ordering